# Haemonetics Stock Surges on CSL Plasma Deal Update

> Haemonetics stock jumps 12.8% after announcing expanded supply deal with CSL Plasma.
- Title: Haemonetics Stock Surges on CSL Plasma Deal Update | Shortify
- Summary: Haemonetics stock jumps 12.8% after announcing expanded supply deal with CSL Plasma. Haemonetics Corporation's stock surged 12.8% to $114.69 following a…
- Keywords: haemonetics, csplasma, medical devices, stock surge, supply deal, Stock, Surges, CSL, Plasma, Deal, Update, Alphastreet - Earnings Decoded. Market Intelligence Delivered
- Source: Alphastreet - Earnings Decoded. Market Intelligence Delivered — https://news.alphastreet.com/haemonetics-hae-surges-12-8-to-114-69
- Author: AlphaStreet Newsdesk
- Published: 2026-10-08T14:32:39+00:00
- Read time: 1 min
- Topics: haemonetics, csplasma, medical devices, stock surge, supply deal
## Haemonetics Stock Surges
Haemonetics Corporation surged 12.8% Thursday, closing at $114.69 after announcing a significant update to its supply deal with CSL Plasma.
## Heavy Trading Volume
The stock’s rally came on heavy volume of 965,767 shares as investors cheered the expanded partnership with one of the world’s largest plasma collectors.
## Strategic Partnership Impact
The catalyst driving the move centers on Haemonetics’ strengthened relationship with CSL Plasma, which provides predictable revenue streams and validation of its technology platform.
## What to Watch Next
Investors should monitor whether Haemonetics can secure similar deals with other major plasma collectors to demonstrate the competitiveness of its platform.
## Key takeaway

Haemonetics Corporation's stock surged 12.8% to $114.69 following a significant update to its supply deal with CSL Plasma.